Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
Cooley LS, Rudewicz J, Souleyreau W, Emanuelli A, Alvarez-Arenas A, Clarke K, Falciani F, Dufies M, Lambrechts D, Modave E, Chalopin-Fillot D, Pineau R, Ambrosetti D, Bernhard JC, Ravaud A, Négrier S, Ferrero JM, Pagès G, Benzekry S, Nikolski M, Bikfalvi A.
Cooley LS, et al. Among authors: emanuelli a.
Mol Cancer. 2021 Oct 20;20(1):136. doi: 10.1186/s12943-021-01416-5.
Mol Cancer. 2021.
PMID: 34670568
Free PMC article.